Trump Administration Health Care Executive OutlookDeep FDA ReformInvestigative Commission on Childhood IllnessesDonald Trump has pledged to appoint Robert Kennedy Jr. as a potential“health czar” to oversee public health agencies, indicating a re-evaluationof food safety and conflicts within the agencies. Kennedy has suggestedreorganizing public health agencies by replacing career senior staff and reprioritizing chronic care.Trump plans to establish a commission of independent experts toinvestigate the root causes of childhood illnesses, granting Kennedysignificant authority to address these issues.NIH ReorganizationPresident Trump aims to elevate U.S. scientific and clinical research,potentially through structural changes at NIH that may align with plansproposed by Republican leadership in the House Energy & CommerceCommittee during the 118th Congress.Health TechnologyThe Trump administration is expected to support health technology with anemphasis on American innovation and cost-efficiency. In health AI, a reviewof recent HHS rules, including those requiring AI developers to report onsafety and bias, may occur, with potential rescissions. Broader leeway onhealth tech coverage decisions and a faster commercialization pace areanticipated, along with progress on cybersecurity.Domestic ManufacturingThe Trump administration is expected to support incentives for domesticmedical manufacturing while penalizing companies that off-shoreoperations or rely heavily on imports through tariffs and taxes, building onCongressional efforts to promote local job creation.BiosecurityWith bipartisan support for the BIOSECURE ACT in the 118th Congress, asignificant push for biosecurity measures and anti-China regulations inbiotech and biopharma is anticipated, likely including restrictions on datatransfer and collaboration with foreign partners.
It seems that your browser's pop-up blocker has prevented us from opening a new window/tab. Please click the button below to open the link manually.